Loading company…
Tydra Labs develops fibrillated chitin biomaterials from crustaceans and fungi.
Tydra Labs develops fibrillated chitin from crustacean shells and fungi for use in agriculture, cosmetics, wound care, and drug delivery. Its materials are designed to improve mechanical, barrier, and antimicrobial properties without toxic additives. Based in Vancouver, Canada, the company raised USD 1.2 mn in pre-seed funding in April 2026, led by Spring Impact Capital.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in